The BREAST-AB Trial is a multi-center, randomized, double blind, placebo-controlled trial
investigating the efficacy of local application of gentamicin, vancomycin and cefazolin in
decreasing all-cause implant explantation after breast reconstruction.
Phase:
Phase 3
Details
Lead Sponsor:
Mikkel Herly
Collaborators:
Herlev and Gentofte Hospital Odense University Hospital Sydvestjysk Hospital University of Copenhagen Vejle Hospital Zealand University Hospital